Summary: Young normal subjects, old normal subjects, and patients with senile dementia of the Alzheimer's type (SDAT) were studied with both computed tomography (CT) and positron emission transaxial tomography (PETT). Increases in ventricular size with both aging and disease were measured. Regional glucose metabolic rate was not affected by age, but was markedly reduced in SDAT pa tients. These data indicate that in normal aging, structural brain changes may be more salient than biochemical Abbreviations used: CM, Canthomeatal; CT, computed to mography; FDG, 18F-2-deoxy-2-fluoro-D-glucose; GDS, Global Deterioration Scale; PETT, positron emission transaxial tomog raphy; SDAT, senile dementia of the Alzheimer's type. It is possible that a number of methodological variables, such as subject selection criteria and methods of scan analysis, may account for these
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changes. Although both structural and biochemical changes occur in SDAT, the biochemical changes are more marked. The results suggest that PETT is potentially more useful than CT in the in vivo diagnosis of SDAT. Key Words: Computed tomography-Global Deterioration Scale-Hemispheric glucose metabolic rate-Pearson product-moment correlations-Positron emission trans axial tomography-Senile dementia of the Alzheimer's type.
Obrist et aI. , 1970; Simard et aI. , 1971; Hagberg and Ingvar, 1976; Yamaguchi et aI. , 1980) , as have the studies with the positron emission trans axial tomography (PETT) technique (Ferris et aI. , 1980; Frackowiak et aI. , 1981; de Leon et aI. , 1983; Ferris et al., 1983) . But studies of normal aging show inconsistent results. In a recent summary of non tomographic studies, Davis et aI. (1983) reported that at least eight studies indicated no age-related changes in oxygen metabolism, whereas four studies report diminutions. The results from PETT studies are also unclear. In related studies, Lammertsma et aI. (1981) and Fieschi and Lenzi (1983) reported a trend of diminishing gray matter oxygen metabo lism with age only until the fIfth decade. Using PETT to study glucose metabolism, Kuhl et al. (1982) found an age-dependent but variable decline in regional metabolic rates, but de Leon et aI. (1983) , Ferris et aI. (1983) , and Rapoport et aI. (1983) found no ev idence for age-related changes in glucose metabo lism.
It is possible that a number of methodological variables, such as subject selection criteria and methods of scan analysis, may account for these inconsistent results (Sokoloff, 1979; . With these considerations in mind, we attempted to resolve the issue of structural versus metabolic change in aging and dementia. We now report the results of the first study, in which both structural data from CT and metabolic data from PETT were obtained on the same groups of young normal, old normal, and SDAT subjects.
SUBJECTS AND METHODS
The groups consisted of 14 young normal subjects (mean age, 26.2 ± 5.3 years), 21 elderly normal subjects (mean age, 67.4 ± 6.7 years), and 23 SDAT patients (mean age, 73.1 ± 6.9 years). All subjects received a clinical evalu ation which included comprehensive medical, neurolog ical, psychiatric, neuropsychological and clinical labora tory assessments. Based upon the 7-point Global Dete rioration Scale (GDS) (Reisberg et aI., 1982) , the global severity of the SDAT patients ranged from mild to severe (GDS = 3-6). Control subjects had GDS scores of 1 or 2.
All clinical studies including CT were performed at NYU Medical Center. CT images were generated by a General Electric GE CT/T 8800 scanner, with one scanning pro tocol for all subjects. The PETT studies were conducted at the Brookhaven National Laboratory with the PETT III scanner. 18F-2-Deoxy-2-fluoro-n-glucose (FDG) was used as a physiologic tracer for glucose. The standardized PETT scanning procedure began after a 30-min tracer uptake period. In all instances, this was an adequate in terval for tracer levels in the blood to reach equilibrium. Throughout the tracer uptake period, the subjects rested with their eyes closed in a quiet, dimly lit scanning room. All scans were taken parallel to the canthomeatal (CM) plane at lO-mm intervals above CM (0 mm).
For the CT analyses, the brain slice was selected that depicted the basal ganglia, the third ventricle, and the pineal body (which was often calcified). A PETT image at a comparable brain level was determined from the fi ducial markings on both imaging machines. From the CT X-ray film, an estimation of structural change was deter mined by the evaluation of ventricular size. The estimate of ventricular size was determined from the following linear measurements: the width of the frontal horns, the 45° width of both frontal horns, the bicaudate diameter, and the width of the third ventricle. In addition, separate brain-width measurements were determined in a plane passing through each ventricular measurement and ex tending from inner table to inner table of the skull. A ventricle-brain ratio was then computed for each ventric ular measure. For the 45° width of the frontal horns, the width of the brain at the level of the third ventricle was used. The arithmetic sum of these ratios was calculated as the composite estimate of ventricular size. We have previously determined that this ventricular size statistic is correlated with overall ventricular volume (r = 0.75; n = 88; p < 0. (001), and has excellent interobserver re liability (r = 0.94, n = 63, p < 0.0001). For PETT, the average metabolic rate was determined for the entire slice and for the right and left hemispheres separately.
Since the SDAT group was slightly but significantly (p < 0.05) older than the elderly normal group, all statistical comparisons between these two groups were controlled for age with covariance analyses and age-corrected means. Correlation analyses involving the two elderly groups em ployed a partial correlation for age.
RESULTS
The CT and PETT results for the three subject groups are presented in Table 1 . Comparisons among the groups indicate that ventricular size increases significantly with normal aging, with a further sig nificant increase in SDAT. Specifically, there is an increase of 13% in the elderly normal subjects rel ative to the young normal subjects, and an increase of 11 % in the SDAT group relative to the elderly controls. For the PETT measures, we find no sta tistically significant differences in glucose metabo lism between the young and the elderly normals.
However, for the SDAT group relative to the elderly controls, there is a highly significant diminution of �23% in the rate of glucose metabolism.
We also examined the degree of relationship be tween the magnitude of the cognitive impairment (GDS score) in the SDAT group, and the extent of f Normal elderly vs. SDAT; p < 0.0001 (age-adjusted).
Values are means ± SD. Values in parentheses are age-adjusted means. (1983), show no relationship between age and spe cific metabolic rate of the surviving tissue. Our find ings do not agree with those of Kuhl et al. (1982) .
The latter study reported "definite," although highly variable, diminutions with increasing age. Although it is possible that some of the inconsistencies in the normal aging and metabolism literature relate to subject selection criteria, it is unclear why the PETT studies involving carefully selected subjects con tinue to find discrepant aging effects. However, with the pathologic aging of SDAT, we find marked met abolic diminutions consistent with most nontomo graphic and PETT studies. Our regional glucose metabolism data reveal a discontinuity between normal aging and SDAT, thereby suggesting a pos sible useful future diagnostic parameter for the in vivo evaluation of SDAT patients. With respect to the threshold hypothesis we have described, it may be that a certain degree of struc tural loss must occur before normal brain metabo lism can no longer be maintained. Alternatively, specific subresolution lesions having more global effects on metabolic and cognitive functions may also occur.
In summary, these data suggest that compared to normal aging, SDAT is marked by greater biochem ical than structural changes. Consequently, PETT may offer the clinician a more effective diagnostic tool than does CT.
